Pharmacokinetic Parameter Driven Outcomes Model Predicts a Reduction in Bleeding Events Associated with BAY 81–8973 Versus Antihemophilic Factor (recombinant) Plasma/albumin-Free Method in a Chinese Healthcare Setting
BMC Medical research methodology（2022）
关键词
Hemophilia A,Factor VIII products,Pharmacokinetic,China,Economic model,BAY 81–8973,rAHF-PFM
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要